๐Ÿ“–
Mesothelin biology and the evolving landscape of targeted immunotherapy
Remy Boisgard, Patrick Chames, Brigitte Kerfelec

Mesothelin biology and the evolving landscape of targeted immunotherapy

Science & Mathematics Published 2026 Verification Pending

Overview & Synopsis

Due to its restricted expression in normal tissues, its frequent overexpression in various aggressive malignancies, and its involvement in several pro-tumorigenic signaling pathways, mesothelin, a glycosylphosphatidylinositol-anchored cell surface protein, has been identified as a promising tumor-associated antigen. This review provides an up-to-date comprehensive overview regarding the role of mesothelin in cancer. It encompasses the protein structural characteristics, expression profiles, glycosylation patterns, shedding mechanisms, prognostic significance, and functional roles. Subsequently, therapeutic strategies targeting mesothelin that have advanced to clinical trial stage are discussed, including vaccine-based approaches, antibody-mediated immunotherapies, and cell therapies. The remaining challenges of mesothelin targeted treatments are highlighted, along with the ongoing options aimed at overcoming these limitations.

Indexed from repository: HAL Open Science (hal.science)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Mesothelin biology and the evolving landscape of targeted immunotherapy
Author / Organization Remy Boisgard, Patrick Chames, Brigitte Kerfelec
Subject & Discipline Multidisciplinary Academic Open Research
Categories Science & Mathematics
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website HAL Open Science (hal.science)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-186437
Original Source Link Visit Source Page on hal.science »